Muhlenkamp & CO Inc Gilead Sciences, Inc. Transaction History

Muhlenkamp & CO Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Aug 18, 2021	SELL	$60.0 - $68.46 $3.05 Million - $3.48 Million	-50,803 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $36,425 - $41,505	643 Added 1.28%	50,803 $2.96 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $46,264 - $58,169	745 Added 1.51%	50,160 $3.17 Million
Q2 2020 Aug 20, 2020	BUY	$72.34 - $84.0 $719,059 - $834,960	9,940 Added 25.18%	49,415 $3.8 Million
Q4 2019 Feb 20, 2020	SELL	$61.62 - $67.78 $5.74 Million - $6.31 Million	-93,134 Reduced 70.23%	39,475 $2.57 Million
Q3 2019 Nov 27, 2019	BUY	$62.51 - $69.0 $3,625 - $4,002	58 Added 0.04%	132,609 $8.41 Million
Q2 2019 Aug 28, 2019	SELL	$61.87 - $69.38 $24,005 - $26,919	-388 Reduced 0.29%	132,551 $8.96 Million
Q1 2019 May 23, 2019	SELL	$62.53 - $70.05 $153,948 - $172,463	-2,462 Reduced 1.82%	132,939 $8.64 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $58,663 - $64,951	-823 Reduced 0.6%	135,401 $10.5 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $5.59 Million - $6.52 Million	-86,153 Reduced 38.74%	136,224 $9.65 Million
Q1 2018 May 11, 2018	BUY	$72.84 - $88.8 $128,489 - $156,643	1,764 Added 0.8%	222,377 $0
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $251,444 - $295,159	-3,534 Reduced 1.58%	220,613 $15.8 Million
Q3 2017 Nov 13, 2017	SELL	$72.11 - $85.47 $110,905 - $131,452	-1,538 Reduced 0.68%	224,147 $18.2 Million
Q2 2017 Aug 11, 2017	BUY	N/A	225,685	225,685 $16 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Muhlenkamp & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Muhlenkamp & CO Inc with notifications on news.